Startups
Edit
ReproCELL Incorporated
https://www.reprocell.com/alvetexLast activity: 24.05.2026
Probably Closed
REPROCELL, founded in 2003, has extensive and accumulated capabilities in iPS cells. As a pioneer with a global outreach in USA, UK, and India, we continue to drive science and applications in research, drug discovery, and regenerative medicine projects.
We also provide biospecimens, preclinical assay services using fresh human tissues, and molecular services, and continue to be a unique tool provider for drug discovery workflow.
We also provide biospecimens, preclinical assay services using fresh human tissues, and molecular services, and continue to be a unique tool provider for drug discovery workflow.
Overview
Location
United States
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 13
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 3, 2026 | REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs | Integrated Workflow Including Clinical Seed Production and StemEdit Gene Editing Services BELTSVILLE, Md., March 3, 2026 /PRNewswire/ -- REPROCELL (TYO: 4978) today announced the launch of its US FDA compliant Good Manufacturing Practice (G... |
| Jan 28, 2026 | REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools | BELTSVILLE, Md., Jan. 29, 2026 /PRNewswire/ -- REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing sy... |
| May 29, 2024 | REPROCELL USA Inaugurates GMP Manufacturing Facility for Stem Cells | REPROCELL is pleased to announce the offering of Master Cell Bank (MCB) manufacturing service for generation of Human Induced Pluripotent Cells (hiPSC) and Human Mesenchymal Stem Cells (hMSC) for human therapeutic applications. BELTSVILLE, ... |
| Jun 2, 2023 | Daily AI Roundup: Biggest Machine Learning, Robotic And Automation Updates 2nd June 2023 | This is our AI Daily Roundup . We are covering the top updates from around the world. The updates will feature state-of-the-art capabilities in artificial intelligence (AI), Machine Learning, Robotic Process Automation, Fintech, and human-s... |
| Jun 1, 2023 | Simplifying AI Data Analysis for Scientists as REPROCELL, IBM and STFC Hartree Centre Successfully Launch Pharmacology-AI Platform | REPROCELL announces the launch of a new commercial service, Pharmacology-AI. The launch follows the completion of one of the first EXCELERATE projects, by the Hartree National Centre for Digital Innovation (HNCDI), via a partnership between... |
| Apr 20, 2022 | REPROCELL Signs Agreement to Prospectively Collect Samples for IFF's Microbiome Study | BELTSVILLE, Md., April 20, 2022 /PRNewswire/ -- REPROCELL and IFF have entered into a clinical services agreement where in, REPROCELL will provide various types of samples for the study titled "Isolation and Characterization of Multipl... |
| Sep 2, 2021 | REPROCELL signs Strategic Collaboration Agreement with TEXCELL to boost its GMP iPSC - Master Cell Bank Manufacturing Service | YOKOHAMA, Japan, Sept. 2, 2021 /PRNewswire/ -- REPROCELL have signed a Strategic Collaboration Agreement with TEXCELL JAPAN, a TEXCELL Group Company, for GMP iPSC - Master Cell Banks (MCB) Manufacturing. The TEXCELL Group (hereinafter "... |
| Jun 7, 2021 | Meet the innovative Japanese life science companies from Yokohama participating in Bio Digital 2021 | For 2021, the BIO International Convention will be again held virtually as “BIO Digital.” This virtual gathering of the global biotech industry provides access to key partners via BIO’s One-on One Partnering system, educational resources to... |
| Sep 29, 2020 | Yokohama joins Maryland Life Sciences’ Bio Innovation Conference through Kanagawa virtual trade delegation | Three Yokohama-based companies will be participating in this year’s Bio Innovation Conference, hosted by Maryland Life Sciences, a division of the Maryland Tech Council. The startups will be joining through a trade mission sponsored by Kana... |
Show more
Reviews 0
FAQ about ReproCELL Incorporated
What has the press written about ReproCELL Incorporated?
Parsers VC has collected 13 articles mentioning ReproCELL Incorporated, among them “REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs” (Mar 3, 2026) and “REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools” (Jan 28, 2026).
Is ReproCELL Incorporated still active?
ReproCELL Incorporated is probably closed: its latest activity on Parsers VC dates from May 24, 2026.